Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bieker

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|October 24, 2007
Getting a charge out of emergency careStephen Barton, Michael Bieker
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|October 17, 2007
Super standardization: one health system, one chargemasterStephen Barton, Michael Bieker
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|March 1, 2012
Dynamic CDM strategies in an EHR environmentMichael Bieker, Spencer Bailey
Cancer Nursing|May 21, 2008
End-of-life care for terminal head and neck cancer patientsAndreas M Sesterhenn, Benedikt J Folz, Michael Bieker, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2010
RapidArc planning and delivery in patients with locally advanced head-and-neck cancer undergoing chemoradiotherapyPatricia Doornaert, Wilko F A R Verbakel, Michael Bieker, et al.
International Journal of Radiation Oncology, Biology, Physics|April 14, 2009
Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric studyWilko F A R Verbakel, Johan P Cuijpers, Daan Hoffmans, et al.
Oral Oncology|February 14, 2009
Botulinum toxin prevents radiotherapy-induced salivary gland damageAfshin Teymoortash, Felix Müller, Janko Juricko, et al.
Oncology Reports|December 22, 2007
Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patientsLin-Fang Wang, Emmanouil Fokas, Michael Bieker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancerClaus Rödel, Torsten Liersch, Robert Michael Hermann, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|October 24, 2007
Getting a charge out of emergency careStephen Barton, Michael Bieker
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|October 17, 2007
Super standardization: one health system, one chargemasterStephen Barton, Michael Bieker
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|March 1, 2012
Dynamic CDM strategies in an EHR environmentMichael Bieker, Spencer Bailey
Cancer Nursing|May 21, 2008
End-of-life care for terminal head and neck cancer patientsAndreas M Sesterhenn, Benedikt J Folz, Michael Bieker, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2010
RapidArc planning and delivery in patients with locally advanced head-and-neck cancer undergoing chemoradiotherapyPatricia Doornaert, Wilko F A R Verbakel, Michael Bieker, et al.
International Journal of Radiation Oncology, Biology, Physics|April 14, 2009
Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric studyWilko F A R Verbakel, Johan P Cuijpers, Daan Hoffmans, et al.
Oral Oncology|February 14, 2009
Botulinum toxin prevents radiotherapy-induced salivary gland damageAfshin Teymoortash, Felix Müller, Janko Juricko, et al.
Oncology Reports|December 22, 2007
Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patientsLin-Fang Wang, Emmanouil Fokas, Michael Bieker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancerClaus Rödel, Torsten Liersch, Robert Michael Hermann, et al.
Pageof 1